Literature DB >> 15944328

Correlates of delayed disease progression in HIV-1-infected Kenyan children.

Rana Chakraborty1, Anne-Sophie Morel, Julian K Sutton, Victor Appay, Ruth M Ripley, Tao Dong, Tim Rostron, Simon Ogola, Tresa Palakudy, Rachel Musoke, Angelo D'Agostino, Mary Ritter, Sarah L Rowland-Jones.   

Abstract

Without treatment most HIV-1-infected children in Africa die before their third birthday (>89%) and long-term nonprogressors are rare. The mechanisms underlying nonprogression in HIV-1-infected children are not well understood. In the present study, we examined potential correlates of delayed HIV disease progression in 51 HIV-1-infected African children. Children were assigned to progression subgroups based on clinical characterization. HIV-1-specific immune responses were studied using a combination of ELISPOT assays, tetramer staining, and FACS analysis to characterize the magnitude, specificity, and functional phenotype of HIV-1-specific CD8(+) and CD4(+) T cells. Host genetic factors were examined by genotyping with sequence-specific primers. HIV-1 nef gene sequences from infecting isolates from the children were examined for potential attenuating deletions. Thymic output was measured by T cell rearrangement excision circle assays. HIV-1-specific CD8(+) T cell responses were detected in all progression groups. The most striking attribute of long-term survivor nonprogressors was the detection of HIV-1-specific CD4(+) Th responses in this group at a magnitude substantially greater than previously observed in adult long-term nonprogressors. Although long-term survivor nonprogressors had a significantly higher percentage of CD45RA(+)CD4(+) T cells, nonprogression was not associated with higher thymic output. No protective genotypes for known coreceptor polymorphisms or large sequence deletions in the nef gene associated with delayed disease progression were identified. In the absence of host genotypes and attenuating mutations in HIV-1 nef, long-term surviving children generated strong CD4(+) T cell responses to HIV-1. As HIV-1-specific helper cells support anti-HIV-1 effector responses in active disease, their presence may be important in delaying disease progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944328     DOI: 10.4049/jimmunol.174.12.8191

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  The role of race and gender in T cell responses in children perinatally infected with HIV-1.

Authors:  Andrea Kovacs; Maria C Villacres
Journal:  J Infect Dis       Date:  2005-10-05       Impact factor: 5.226

2.  Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239.

Authors:  Nancy A Wilson; Jason Reed; Gnankang S Napoe; Shari Piaskowski; Andy Szymanski; Jessica Furlott; Edna J Gonzalez; Levi J Yant; Nicholas J Maness; Gemma E May; Taeko Soma; Matthew R Reynolds; Eva Rakasz; Richard Rudersdorf; Adrian B McDermott; David H O'Connor; Thomas C Friedrich; David B Allison; Amit Patki; Louis J Picker; Dennis R Burton; Jing Lin; Lingyi Huang; Deepa Patel; Gwendolyn Heindecker; Jiang Fan; Michael Citron; Melanie Horton; Fubao Wang; Xiaoping Liang; John W Shiver; Danilo R Casimiro; David I Watkins
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.

Authors:  V Traina-Dorge; B Pahar; P Marx; P Kissinger; D Montefiori; Y Ou; W L Gray
Journal:  Vaccine       Date:  2010-07-21       Impact factor: 3.641

4.  Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?

Authors:  M Hainaut; V Verscheure; M Ducarme; L Schandené; J Levy; F Mascart
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

5.  Impact of ERCC2 gene polymorphism on HIV-1 disease progression to AIDS among North Indian HIV patients.

Authors:  Ranbir Chander Sobti; Nega Berhane; Salih Abdul Mahdi; Rupinder Kler; Seyed Ali Hosseini; Vijish Kuttiat; Ajay Wanchu
Journal:  Mol Biol Rep       Date:  2010-02-02       Impact factor: 2.316

Review 6.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

7.  Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge.

Authors:  Elizabeth J Faul; Pyone P Aye; Amy B Papaneri; Bapi Pahar; James P McGettigan; Faith Schiro; Inna Chervoneva; David C Montefiori; Andrew A Lackner; Matthias J Schnell
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

Review 8.  Immune pathogenesis of pediatric HIV-1 infection.

Authors:  Caroline T Tiemessen; Louise Kuhn
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

9.  Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda.

Authors:  Oliver Laeyendecker; Andrew D Redd; Tom Lutalo; Ronald H Gray; Maria Wawer; Victor Ssempijja; Jordyn Gamiel; John Baptist Bwanika; Fred Makumbi; Fred Nalugoda; Pius Opendi; Godfrey Kigozi; Anthony Ndyanabo; Boaz Iga; Noah Kiwanuka; Nelson Sewankambo; Steven J Reynolds; David Serwadda; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

Review 10.  HIV-1 co-receptor usage: influence on mother-to-child transmission and pediatric infection.

Authors:  Mariangela Cavarelli; Gabriella Scarlatti
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.